BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND BAP1, DKFZp686N04275, 8314, ENSG00000163930, Q92560, KIAA0272, hucep-6, HUCEP-13, FLJ37180, FLJ35406
47 results:

  • 1. Germline mutations of homologous recombination genes and clinical outcomes in pancreatic cancer: a multicenter study in Taiwan.
    Cheng SM; Su YY; Chiang NJ; Wang CJ; Chao YJ; Huang CJ; Tsai HJ; Chen SH; Chang CY; Tsai CR; Li YJ; Yen CJ; Chuang SC; Chang JS; Shan YS; Hwang DY; Chen LT
    J Biomed Sci; 2024 Feb; 31(1):21. PubMed ID: 38350919
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Characterization of Potential Melanoma Predisposition Genes in High-Risk Brazilian Patients.
    Soares de Sá BC; Moredo LF; Torrezan GT; Fidalgo F; de Araújo ÉSS; Formiga MN; Duprat JP; Carraro DM
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958811
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. High- and intermediate-risk susceptibility variants in melanoma families from the Mediterranean area: A multicentre cohort from the MelaNostrum Consortium.
    Pellegrini C; Cardelli L; Ghiorzo P; Pastorino L; Potrony M; García-Casado Z; Elefanti L; Stefanaki I; Mastrangelo M; Necozione S; Aguilera P; Rodríguez-Hernández A; Di Nardo L; Rocco T; Del Regno L; Badenas C; Carrera C; Malvehy J; Requena C; Bañuls J; Stratigos AJ; Peris K; Menin C; Calista D; Nagore E; Puig S; Landi MT; Fargnoli MC
    J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):2498-2508. PubMed ID: 37611275
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms.
    Venizelos A; Sorbye H; Elvebakken H; Perren A; Lothe IMB; Couvelard A; Hjortland GO; Sundlöv A; Svensson J; Garresori H; Kersten C; Hofsli E; Detlefsen S; Vestermark LW; Ladekarl M; Tabaksblat EM; Knappskog S
    Endocr Relat Cancer; 2023 Oct; 30(10):. PubMed ID: 37410378
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A phase 1/2a safety, pharmacokinetics, and efficacy study of the novel nucleoside analog FF-10502-01 for the treatment of advanced solid tumors.
    Janku F; Javle MM; Sen S; Pant S; Bramwell LG; Subbiah V; Way T; Wages DS; Wheeler CA; Suzuki T; Saeki K; Subach RA; Madden T; Maier G; Johansen MJ; Cheung K; Falchook GS
    Cancer; 2023 May; 129(10):1537-1546. PubMed ID: 36882377
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Two unique bap1 pathogenic variants identified in the same family by panel cascade testing.
    Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
    Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (bap1): Friend or foe?
    Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
    Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup.
    Bruno W; Dalmasso B; Barile M; Andreotti V; Elefanti L; Colombino M; Vanni I; Allavena E; Barbero F; Passoni E; Merelli B; Pellegrini S; Morgese F; Danesi R; Calò V; Bazan V; D'Elia AV; Molica C; Gensini F; Sala E; Uliana V; Soma PF; Genuardi M; Ballestrero A; Spagnolo F; Tanda E; Queirolo P; Mandalà M; Stanganelli I; Palmieri G; Menin C; ; Pastorino L; Ghiorzo P
    ESMO Open; 2022 Aug; 7(4):100525. PubMed ID: 35777164
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular Characterization of KRAS Wild-type Tumors in Patients with pancreatic Adenocarcinoma.
    Philip PA; Azar I; Xiu J; Hall MJ; Hendifar AE; Lou E; Hwang JJ; Gong J; Feldman R; Ellis M; Stafford P; Spetzler D; Khushman MM; Sohal D; Lockhart AC; Weinberg BA; El-Deiry WS; Marshall J; Shields AF; Korn WM
    Clin Cancer Res; 2022 Jun; 28(12):2704-2714. PubMed ID: 35302596
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pan-cancer Analysis of Homologous Recombination Repair-associated Gene Alterations and Genome-wide Loss-of-Heterozygosity Score.
    Westphalen CB; Fine AD; André F; Ganesan S; Heinemann V; Rouleau E; Turnbull C; Garcia Palacios L; Lopez JA; Sokol ES; Mateo J
    Clin Cancer Res; 2022 Apr; 28(7):1412-1421. PubMed ID: 34740923
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Histological and immunohistochemical characteristics and
    Fujishima F; Konosu-Fukaya S; Nabeshima K; McNamara KM; Sakamoto K; Sakurada J; Sasano H; Nakamura Y
    Indian J Pathol Microbiol; 2021; 64(2):277-281. PubMed ID: 33851620
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Roles and mechanisms of bap1 deubiquitinase in tumor suppression.
    Masclef L; Ahmed O; Estavoyer B; Larrivée B; Labrecque N; Nijnik A; Affar EB
    Cell Death Differ; 2021 Feb; 28(2):606-625. PubMed ID: 33462414
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix.
    Park E; Kim SW; Kim S; Kim HS; Lee JY; Kim YT; Cho NH
    Mod Pathol; 2021 Mar; 34(3):637-646. PubMed ID: 32641744
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. bap1 is a haploinsufficient tumor suppressor linking chronic pancreatitis to pancreatic cancer in mice.
    Perkail S; Andricovich J; Kai Y; Tzatsos A
    Nat Commun; 2020 Jun; 11(1):3018. PubMed ID: 32541668
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Characteristics of genomic alterations in Chinese cholangiocarcinoma patients.
    Jiang G; Zhang W; Wang T; Ding S; Shi X; Zhang S; Shi W; Liu A; Zheng S
    Jpn J Clin Oncol; 2020 Sep; 50(10):1117-1125. PubMed ID: 32533190
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection.
    Park W; Chen J; Chou JF; Varghese AM; Yu KH; Wong W; Capanu M; Balachandran V; McIntyre CA; El Dika I; Khalil DN; Harding JJ; Ghalehsari N; McKinnell Z; Chalasani SB; Makarov V; Selenica P; Pei X; Lecomte N; Kelsen DP; Abou-Alfa GK; Robson ME; Zhang L; Berger MF; Schultz N; Chan TA; Powell SN; Reis-Filho JS; Iacobuzio-Donahue CA; Riaz N; O'Reilly EM
    Clin Cancer Res; 2020 Jul; 26(13):3239-3247. PubMed ID: 32444418
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Loss of bap1 Leads to More YAPing in pancreatic cancer.
    Brekken RA
    Cancer Res; 2020 Apr; 80(8):1624-1625. PubMed ID: 32295782
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. pancreatic tropism of metastatic renal cell carcinoma.
    Singla N; Xie Z; Zhang Z; Gao M; Yousuf Q; Onabolu O; McKenzie T; Tcheuyap VT; Ma Y; Choi J; McKay R; Christie A; Torras OR; Bowman IA; Margulis V; Pedrosa I; Przybycin C; Wang T; Kapur P; Rini B; Brugarolas J
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271170
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Biliary intraductal tubule-forming neoplasm: a whole exome sequencing study of MUC5AC-positive and -negative cases.
    Akita M; Hong SM; Sung YN; Kim MJ; Ajiki T; Fukumoto T; Itoh T; Zen Y
    Histopathology; 2020 Jun; 76(7):1005-1012. PubMed ID: 32181510
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The Tumor Suppressor bap1 Regulates the Hippo Pathway in pancreatic Ductal Adenocarcinoma.
    Lee HJ; Pham T; Chang MT; Barnes D; Cai AG; Noubade R; Totpal K; Chen X; Tran C; Hagenbeek T; Wu X; Eastham-Anderson J; Tao J; Lee W; Bastian BC; Carbone M; Webster JD; Dey A
    Cancer Res; 2020 Apr; 80(8):1656-1668. PubMed ID: 31988076
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.